Correlation Between Atea Pharmaceuticals and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Atea Pharmaceuticals and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atea Pharmaceuticals and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atea Pharmaceuticals and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Atea Pharmaceuticals and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atea Pharmaceuticals with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atea Pharmaceuticals and Anebulo Pharmaceuticals.
Diversification Opportunities for Atea Pharmaceuticals and Anebulo Pharmaceuticals
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Atea and Anebulo is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Atea Pharmaceuticals and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Atea Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atea Pharmaceuticals are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Atea Pharmaceuticals i.e., Atea Pharmaceuticals and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Atea Pharmaceuticals and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Atea Pharmaceuticals is expected to under-perform the Anebulo Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Atea Pharmaceuticals is 1.59 times less risky than Anebulo Pharmaceuticals. The stock trades about -0.26 of its potential returns per unit of risk. The Anebulo Pharmaceuticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 158.00 in Anebulo Pharmaceuticals on November 3, 2024 and sell it today you would lose (4.00) from holding Anebulo Pharmaceuticals or give up 2.53% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Atea Pharmaceuticals vs. Anebulo Pharmaceuticals
Performance |
Timeline |
Atea Pharmaceuticals |
Anebulo Pharmaceuticals |
Atea Pharmaceuticals and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Atea Pharmaceuticals and Anebulo Pharmaceuticals
The main advantage of trading using opposite Atea Pharmaceuticals and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atea Pharmaceuticals position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |